# GLP-1s in Hip and Knee Arthroplasty

> **NCT07755085** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 100 (estimated)

## Conditions studied

- Arthritis
- Obesity & Overweight
- GLP - 1

## Interventions

- **DRUG:** GLP-1 Receptor Agonists + Behavioral modification
- **BEHAVIORAL:** Behavioral + placebo

## Key facts

- **NCT ID:** NCT07755085
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07755085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07755085, "GLP-1s in Hip and Knee Arthroplasty". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07755085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*